10X GENOMICS, INC. - Annual Financials - Equity (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

10X GENOMICS, INC. - Annual Equity (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Beginning balance (in shares)	122291.837	119095.362	115195.009
Beginning balance	2	2025890	805743
Issuance of Class A common stock related to equity awards (in shares)	3196.475	3900.353	2680.032
Issuance of Class A common stock related to equity awards	10914	19483	21226
Vesting of shares subject to repurchase, including early exercised options			96
Stock-based compensation	140868	167010	137210
Net loss	-182627	-255099	-166000
Other comprehensive income (loss)	-64	3906	-4357
Ending balance (in shares)	122291.837	119095.362	115195.009
Ending balance	2	2025890	805743